Company: PMVP
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001140361-25-015610
Chunk: 51

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 51
---
 of the Scott Z. Heyman 2016 Irrevocable Trust, of which Dr. Heyman’s son and descendants are beneficiaries, exercisable within 60 days of April 8, 2025. |

| (13) | Consists of (i) 409,842 shares of common stock held directly by Dr. Levine and (ii) 100,614 shares of common stock issuable pursuant to options held directly by Dr. Levine, exercisable within 60 days of April 8, 2025. |

| (14) | Consists of 127,500 shares of common stock issuable pursuant to options held directly by Ms. Stelzer, exercisable within 60 days of April 8, 2025. |

| (15) | Consists of (i) 1,597,645 shares of common stock beneficially owned by our current executive officers and directors as of April 8, 2025 and (ii) 2,524,802 shares of common stock issuable pursuant to options beneficially owned by our current executive officers and directors, exercisable within 60 days of April 8, 2025. |

30

TABLE OF CONTENTS DELINQUENT SECTION 16(A) REPORTS Section 16(a) of the Exchange Act requires that our directors and executive officers, and persons who own more than 10% of our common stock, file reports of ownership and changes in ownership with the SEC. Such persons are required by SEC regulations to furnish us with copies of all Section 16(a) forms filed by such persons. To our knowledge, no person who, during the fiscal year ended December 31, 2024, was a director or officer of the Company, or beneficial owner of more than ten percent of our common stock (which is the only class of securities registered under Section 12 of the Securities Act), failed to file on a timely basis reports required by Section 16 of the Exchange Act during such fiscal year, except that, as a result of Company administrative error, on October 3, 2024, three Form 4 filings for David H. Mack, Ph.D., Michael Carulli and Deepika Jalota were inadvertently filed later than the time prescribed by the SEC. Such Form 4 filings related to the cancellation of stock options to purchase shares of the Company’s common stock and the issuance of new stock options to purchase shares of the Company’s common stock pursuant to the Tender Offer. Additionally, on January